Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.

Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT

Open access
Dakic, Vanja, Minardi Nascimento, Juliana, Costa Sartore, Rafaela, Maciel, Renata de Moraes, de Araujo, Draulio B., Ribeiro, Sidarta, Martins-de-Souza, Daniel, Rehen, Stevens K. · 2017 · Scientific Reports

Published version of a preprint

Abstract

Dimethyltryptamines are entheogenic serotonin-like molecules present in traditional Amerindian medicine recently associated with cognitive gains, antidepressant effects, and changes in brain areas related to attention. Legal restrictions and the lack of adequate experimental models have limited the understanding of how such substances impact human brain metabolism. Here we used shotgun mass spectrometry to explore proteomic differences induced by 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) on human cerebral organoids. Out of the 6,728 identified proteins, 934 were found differentially expressed in 5-MeO-DMT-treated cerebral organoids. In silico analysis reinforced previously reported anti-inflammatory actions of 5-MeO-DMT and revealed modulatory effects on proteins associated with long-term potentiation, the formation of dendritic spines, including those involved in cellular protrusion formation, microtubule dynamics, and cytoskeletal reorganization. Our data offer the first insight about molecular alterations caused by 5-MeO-DMT in human cerebral organoids.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-12779-5

Cites

91 of 91 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of 5-MeO-DMT on hNPCs. (A) Expression of mRNA for internal control (GAPDH), SR1, 5-HT2A, and 5-HT2C in hNPCs. (B) Confirmation of σ-1R protein (green) expression by immunocytochemistry, phalloidin showing the cytoskeleton (red) and DAPI staining nuclei (blue), scale bar 20 μm. (C) Quantification of cell proliferation based on EdU staining after treatment with 5-MeO-DMT. (D) Percentage of dead cells in hNPCs treated with 5-MeO-DMT. (E–H) Effects of 5-MeO-DMT on neuronal arborization by quantification of (E) total neurite length (sum of the length of all neurites attached to the cell), (F) number of segments, (G) number of extremities, and (H) number of nodes type 1. Bar represents median. Data were analyzed by one-way ANOVA with Tukey’s multiple comparison test, and only p-values < 0.05 were considered significant. Here, all comparisons showed p-values > 0.05.
Figure 1 Effects of 5-MeO-DMT on hNPCs. (A) Expression of mRNA for internal control (GAPDH), SR1, 5-HT2A, and 5-HT2C in hNPCs. (B) Confirmation of σ-1R protein (green) expression by immunocytochemistry, phalloidin showing the cytoskeleton (red) and DAPI staining nuclei (blue), scale bar 20 μm. (C) Quantification of cell proliferation based on EdU staining after treatment with 5-MeO-DMT. (D) Percentage of dead cells in hNPCs treated with 5-MeO-DMT. (E–H) Effects of 5-MeO-DMT on neuronal arborization by quantification of (E) total neurite length (sum of the length of all neurites attached to the cell), (F) number of segments, (G) number of extremities, and (H) number of nodes type 1. Bar represents median. Data were analyzed by one-way ANOVA with Tukey’s multiple comparison test, and only p-values < 0.05 were considered significant. Here, all comparisons showed p-values > 0.05.CC BY · PubMed Central
Figure 2 Cerebral organoids express 5-MeO-DMT receptors and different cell type markers. (A) Cerebral organoids presenting smooth texture and homogeneous coloring at 45 days of differentiation (scale bar 1000 μm). (B) Cerebral organoids are composed of several cell types, including mature neurons, as shown by MAP2 staining. (C) Cells expressing AMPAR1 are found at the organoid edge, while (D) cells expressing NMDAR1 and (E) GFAP are detected within the organoid. (F) Cells positive for 5-HT2A receptor, and (G) σ-1R, the primary molecular targets for 5-MeO-DMT, are also found in the organoid. Scale bars: A = 1000 μm; B = 50 μm; C, D, E, F, and G = 20 μm. (H) The expression of molecular targets for 5-MeO-DMT was also confirmed by RT-PCR.
Figure 2 Cerebral organoids express 5-MeO-DMT receptors and different cell type markers. (A) Cerebral organoids presenting smooth texture and homogeneous coloring at 45 days of differentiation (scale bar 1000 μm). (B) Cerebral organoids are composed of several cell types, including mature neurons, as shown by MAP2 staining. (C) Cells expressing AMPAR1 are found at the organoid edge, while (D) cells expressing NMDAR1 and (E) GFAP are detected within the organoid. (F) Cells positive for 5-HT2A receptor, and (G) σ-1R, the primary molecular targets for 5-MeO-DMT, are also found in the organoid. Scale bars: A = 1000 μm; B = 50 μm; C, D, E, F, and G = 20 μm. (H) The expression of molecular targets for 5-MeO-DMT was also confirmed by RT-PCR.CC BY · PubMed Central
Figure 3 5-MeO-DMT treatment effects on human cerebral organoid proteomics. (A) Experimental design workflow. 45-day-old cerebral organoids were treated with either 5-MeO-DMT, vehicle, or left untreated for 24 h. Samples were analyzed using label-free state-of-the-art quantitative proteomics, using two-dimensional fractionation and high-resolution mass spectrometry. Workflow art was modified from29. (B) Venn diagram comparing the number of proteins identified by shotgun mass spectrometry in control human cerebral organoids, those treated with vehicle (EtOH), and 5-MeO-DMT. (C) Heat map showing significant functional enrichment between 5-MeO-DMT versus vehicle human cerebral organoids.
Figure 3 5-MeO-DMT treatment effects on human cerebral organoid proteomics. (A) Experimental design workflow. 45-day-old cerebral organoids were treated with either 5-MeO-DMT, vehicle, or left untreated for 24 h. Samples were analyzed using label-free state-of-the-art quantitative proteomics, using two-dimensional fractionation and high-resolution mass spectrometry. Workflow art was modified from29. (B) Venn diagram comparing the number of proteins identified by shotgun mass spectrometry in control human cerebral organoids, those treated with vehicle (EtOH), and 5-MeO-DMT. (C) Heat map showing significant functional enrichment between 5-MeO-DMT versus vehicle human cerebral organoids.CC BY · PubMed Central
Figure 4 Schematic representation of the changes in protein expression of NFAT and NF-κB pathways by 5-MeO-DMT. Canonical pathways showing upregulated (red) and downregulated proteins (green) after 5-MeO-DMT treatment.
Figure 4 Schematic representation of the changes in protein expression of NFAT and NF-κB pathways by 5-MeO-DMT. Canonical pathways showing upregulated (red) and downregulated proteins (green) after 5-MeO-DMT treatment.CC BY · PubMed Central
Figure 5 Schematic representation of long term potentiation modulation by 5-MeO-DMT treatment. Z-scores were calculated from an upstream shortest-path analysis and gave the probability that the interaction between the proteins and the common regulator is not occurring by chance. In red, upregulated proteins; in green, downregulated proteins after 5-MeO-DMT treatment. Glu, glutamate.
Figure 5 Schematic representation of long term potentiation modulation by 5-MeO-DMT treatment. Z-scores were calculated from an upstream shortest-path analysis and gave the probability that the interaction between the proteins and the common regulator is not occurring by chance. In red, upregulated proteins; in green, downregulated proteins after 5-MeO-DMT treatment. Glu, glutamate.CC BY · PubMed Central
Figure 6 Pathway showing influence of 5-MeO-DMT on cytoskeletal reorganization and dendritic spine morphogenesis. Canonical pathway showing upregulated (red) and downregulated (green) proteins.
Figure 6 Pathway showing influence of 5-MeO-DMT on cytoskeletal reorganization and dendritic spine morphogenesis. Canonical pathway showing upregulated (red) and downregulated (green) proteins.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Holmstedt, B. & Lindgren, J. Chemical constituents and pharmacology of South American snuffs. Psychopharmacol Bull 4, 16 (1967).

Cited by

See all 134

Metadata

Authors
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K.
Affiliations
  • Universidade Federal do Rio de Janeiro (BR)
  • D’Or Institute for Research and Education (BR)
  • Universidade Federal do Rio Grande do Norte (BR)
Corresponding author
Rehen, Stevens K.
Venue
Scientific Reports
Published
2017-10-09
Volume
7
Issue
1
Pages
12863-12863
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2761558601
Cited by
134
References
91
Citations by year
2026: 14 · 2025: 19 · 2024: 16 · 2023: 12 · 2022: 19 · 2021: 18 · 2020: 15 · 2019: 11 · 2018: 8
FWCI
11.42
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/, 2013/0 8711–3, 2014/21035-0, 13/08711-3, 2014/10 068–4, 14/10068-4)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2014/10068-4, 2013/08711-3)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (2014/10068-4, 2013/08711-3)
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Financiadora de Estudos e Projetos
  • Banco Nacional de Desenvolvimento Econômico e Social
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
5-MeO-DMT, dimethyltryptamine, entheogens, brain organoids, proteome changes, differentially expressed proteins, anti-inflammatory activity, long-term potentiation, dendritic spines, microtubule dynamics, cytoskeletal remodeling, brain metabolism
MeSH terms
Cell Line, Cytoskeleton, Humans, Methoxydimethyltryptamines, Morphogenesis, Nerve Tissue Proteins, Organoids, Time Factors, Signal Transduction, Biomarkers, NF-kappa B, Long-Term Potentiation, Proteome, Proteomics, Dendritic Spines, NFATC Transcription Factors, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. https://app.cochat.ai/papers/10.1038/s41598-017-12779-5
The paper
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. D. M., de Araujo, D. B., Ribeiro, S., Martins-de-Souza, D., & Rehen, S. K. (2017). Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Scientific Reports. https://doi.org/10.1038/s41598-017-12779-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.